(Q68531900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

title

Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

author name string

W Sadée

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

U Abshagen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

C Finn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

N Rietbrock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 January 1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

303-318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00499190

25 September 2019

exact match

0 references

cites work

Cerebral uptake of a 3 H-labelled spirolactone compound in the dog.

1 reference

12 December 2020

Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone

1 reference

12 December 2020

Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone®)

1 reference

12 December 2020

TUBULAR EFFECTS AND RENAL ELIMINATION OF SPIROLACTONES

1 reference

12 December 2020

Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans

1 reference

12 December 2020

Disposition of Tritium-Labeled Spirolactones in the Dog

1 reference

12 December 2020

Fluorometric Microassay for Spironolactone and Its Metabolites in Biological Fluids

1 reference

12 December 2020

PHARMACOLOGICAL PROPERTIES OF A MINERALOCORTICOID ANTAGONIST (SC-14266)

1 reference

12 December 2020

Studies on organ- and subcellular distribution of 3 H-spironolactone in animals

1 reference

12 December 2020

ON THE METABOLISM OF 3-(3-OXO-7-ALPHA-ACETYLTHIO-17-BETA-HYDROXY-4-ANDROSTEN-17-ALPHA-YL)-PROPIONIC ACID-GAMMA-LACTONE

1 reference

12 December 2020

Plasma Levels of Spirolactones in the Dog

1 reference

12 December 2020

RELATIONSHIP OF PLASMA ALDADIENE LEVELS AND ANTIMINERALOCORTICOID EFFECTS OF SPIRONOLACTONE IN THE LABORATORY

1 reference

12 December 2020

Pharmacokinetic and Metabolic Fate of Potassium Canrenoate (SC-14266) in Man

1 reference

12 December 2020

Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00499190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4276758%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference